Eli Lilly clinical miss has effects across pharma By: CNBC.com News October 12, 2015 at 15:32 PM EDT The same drug development news that's hurting Eli Lilly shares might be good for Amgen and Sanofi-Regeneron. Read More >> Related Stocks: Amgen Eli Lilly Merck & Co Regeneron Pharmaceuticals Sanofi-Aventis S.A. ADR